Texas judge in Tylenol case won't block Kenvue's $398 million dividend payment

A Texas judge cleared the way for Kenvue to pay a $398 million shareholder dividend this month, a win for the U.S. consumer health company in a politically-charged legal battle over the safety of using Tylenol during pregnancy.
The Motley Fool on MSN

2 Outstanding Dividend Stocks That Are Too Cheap to Ignore

These cheap dividend stocks would make great cornerstone pieces to any portfolio -- especially for investors looking for a deal in today's somewhat expensive market.

Texas State Judge Won't Block Kenvue From Paying Dividend, Company Lawyer Says

WILMINGTON, DEL. (Reuters) -A Texas state judge won't block Kenvue from paying its scheduled November 26 shareholder dividend, rejecting a request by Texas Attorney General Ken Paxton, a Kenvue lawyer told Reuters on Friday.

Texas judge in Tylenol case won't block Kenvue from paying dividend, lawyer says

A Texas state judge said she won't block Kenvue from paying its scheduled $398 million shareholder dividend on November 26, rejecting a request by Texas Attorney General Ken Paxton, a Kenvue lawyer told Reuters on Friday.

Pfizer's Rich Dividend Story Meets Overpriced Metsera Acquisition/Patent Cliff Risks

Pfizer offers strong dividends, solid cash flow coverage, discounted value and key risks from patent cliffs, pricing and costly deals. See why PFE stock is a buy.
Feedback